FATIGUE POST VIRAL
Clinical trials for FATIGUE POST VIRAL explained in plain language.
Never miss a new study
Get alerted when new FATIGUE POST VIRAL trials appear
Sign up with your email to follow new studies for FATIGUE POST VIRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood infusion now available for long COVID patients under expanded access
Disease control AVAILABLEThis expanded access program offers REGENECYTE, a human umbilical cord blood infusion, to adults with Long COVID who cannot join other clinical trials. Participants must have a recent negative COVID-19 test and provide consent. The goal is to provide potential treatment access wh…
Matched conditions: FATIGUE POST VIRAL
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to ease chronic fatigue with simple therapy
Symptom relief Recruiting nowThis study looks at whether a type of talking therapy (cognitive behavioral therapy) can help reduce severe fatigue in primary care patients. About 190 adults aged 18-67 with long-lasting fatigue will either get the therapy or usual care. The goal is to see if the therapy improve…
Matched conditions: FATIGUE POST VIRAL
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Why do some teens stay fatigued after mono? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at why some teenagers and young adults feel tired for months after getting Epstein-Barr virus (the virus that causes mono). Researchers will follow 150 infected people and 150 healthy people for six months, using brain scans, immune tests, and questionnaires. The…
Matched conditions: FATIGUE POST VIRAL
Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC